Subscribe for stories that matter!
Doylestown-based Aprea Therapeutics, a leader in precision oncology, has successfully secured a financing deal anticipated to bring in up to $34 million in proceeds…
A Bucks County biotechnology center pilot program is seeking to bring life sciences companies to the Keystone State, writes John George for the Philadelphia Business…
Aprea Therapeutics, Inc., headquarted at 3805 Old Easton Road in Doylestown, has reported their financial results for the second fiscal quarter of 2023. Staff writers…
Before we send you to this site, please subscribe to our daily newsletter.